[topsearch__bar__shortcode]

January 25, 2022

GOCO Stock

Mind Medicine (MindMed) Inc. (MNMD) surged in the Pre-market; here is why?

Mind Medicine (MindMed) Inc. (MNMD) stock gained in the pre-market after the Company announced that IND had been cleared. MNMD values at $1.05, gaining more than 12% from the previously closed value. At the end of the last trading session, the stock closed at around $0.93. The stock volume traded in the previous trading session […]

Mind Medicine (MindMed) Inc. (MNMD) surged in the Pre-market; here is why? Read More »

ENSV Stock

Sierra Oncology, Inc. (SRRA) stock is jumping high – What’s going on?

Sierra Oncology, Inc. (SRRA) has seen an increase of 64.15% in the premarket after the company announced a financial update to Support the Commercialization of Momelotinib. However, the last trading session concluded at $15.51 with a decrease of 8.06%. Commercialization of Momelotinib – What’s up? On 25th January 2022, SRRA reported that it has signed

Sierra Oncology, Inc. (SRRA) stock is jumping high – What’s going on? Read More »

How Worried Should Investors Be About G Medical (GMVD)?

G Medical Innovations Holdings Ltd (GMVD) shares have added 14.32% to finish last trading session at $4.95. The G Medical (GMVD) stock recorded a trading volume of 12.8 million shares, which is below the average daily trading volume published for the last 50 days of 2.14 million shares. The shares of GMVD have retreated 41.43%

How Worried Should Investors Be About G Medical (GMVD)? Read More »

Here’s the Reason Why Capricor Therapeutics, Inc. (CAPR) Stock is Roaring in the Premarket

Capricor Therapeutics, Inc. (CAPR) is a biopharmaceutical company engaged in the development of therapeutics for treating an array of diseases. The company’s pipeline product candidate includes CAP-1002 used for treating Duchenne muscular dystrophy and the cytokine storm in COVID-19 patients. The Company is also developing exosomes capable of delivering nucleic acids to treat different diseases.

Here’s the Reason Why Capricor Therapeutics, Inc. (CAPR) Stock is Roaring in the Premarket Read More »

Do Investors Have Much Faith In Flora Growth (FLGC)?

Flora Growth Corp. (FLGC) stock closed last session at $1.665, increasing 14.83% or $0.215. Shares of Flora Growth (FLGC) fluctuated between $1.31 and $1.68 throughout the day. The number of shares exchanged was 1.30 million, less than the company’s 50-day daily volume of 1.63 million. In the past last one week, the stock has moved

Do Investors Have Much Faith In Flora Growth (FLGC)? Read More »

Reviva Pharmaceuticals Holdings, Inc. (RVPH) stock is down in premarket – Here’s why?

Reviva Pharmaceuticals Holdings, Inc. (RVPH) experienced a decrease of 6.38% in the premarket. However, the last trading session concluded at $1.88 with an increase of  8.67%. Letter for Pivotal Phase 3 Clinical Trial – Latest Updates by RVPH On 10th January 2022, RVPH announced that brilaroxazine has been approved by the US Food and Drug

Reviva Pharmaceuticals Holdings, Inc. (RVPH) stock is down in premarket – Here’s why? Read More »

Things For Investors To Watch In Kohl’s Corporation (KSS)

Kohl’s Corporation (KSS) has gained 36.02% to complete the last trading session at $63.71. The price range of Kohl’s (KSS) shares was between $60.82 and $63.85. KSS stock traded 41.73 million shares, which was above its daily average of 4.58 million shares over 100 days. KSS shares have gained by 33.37% in the last five

Things For Investors To Watch In Kohl’s Corporation (KSS) Read More »

Investors Getting Picky When It Comes To Buying Exterran (EXTN)

Exterran Corporation (EXTN) shares gained 59.67% to close Monday’s session at $4.79. Exterran (EXTN) stock volume remained 60.86 million shares, which was higher than the average daily volume of 1.55 million shares within the past 50 days. EXTN shares have risen by 1.91% over the last 12 months, and they have moved up by 35.31%

Investors Getting Picky When It Comes To Buying Exterran (EXTN) Read More »

Here’s What you Should Know About Inclining Premarket Stock of Aptorum Group Ltd. (APM)

Aptorum Group Ltd. (APM) is a leading biotherapeutics company. It is engaged in the development and commercialization of treatments for oncology and infectious diseases. The company also focuses on its therapeutics platform for gastro and metabolic issues along with women’s health. The price of APM stock during the regular trading on January 24, 2022 was

Here’s What you Should Know About Inclining Premarket Stock of Aptorum Group Ltd. (APM) Read More »